MP Biomedicals FastGro synthetic, animal-free, chemically defined FBS replacement

Tuesday, 01 October, 2019 | Supplied by: MP Biomedicals Australasia P/L

MP Biomedicals FastGro synthetic, animal-free, chemically defined FBS replacement

FastGro is a fully chemically defined replacement for foetal bovine serum. Designed for use in cell culture, it can help mitigate common concerns associated with FBS while promoting cell growth and consistency.

Foetal bovine serum (FBS) is widely used as a supplement for in vitro cell culture media. FBS promotes healthy cell growth by providing an undefined mixture of nutrients, such as proteins, attachment factors, growth factors, lipids and hormones.

Due to its undefined nature, FBS can lead to unexpected and undesired stimulation of cells. There is also biorisk from animal protein or pathogen contamination, including risk of bovine spongiform encephalopathy (BSE).

FastGro supports the growth of a wide range of cells in vitro without the use of serum or any animal- or human-derived compounds. When used in cell culture, it offers chemically defined nature without lot-to-lot variation; no animal- or human-derived materials or compounds; no interference with hormones or growth factors; and the elimination of the risk of contaminants (viruses, mycoplasma, prions, etc).

The product is easy to use and suitable for a wide range of cell culture applications. It can be stored in the refrigerator, so there is no need for thawing prior to use.

For more information, click here.

Online: www.mpbio.com/au/
Phone: +61 2 8824 2100
Related Products

AlphaThera oYo-Link Antibody Labeling Reagents

AlphaThera's oYo-Link Antibody Labeling Reagents enable site-specific antibody labelling....

Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers

The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...

RevMAb Biosciences histone family protein monoclonal antibodies

RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd